Provided By PR Newswire
Last update: Oct 3, 2025
NEW YORK, Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:AXGN (10/28/2025, 1:33:44 PM)
17.195
-0.57 (-3.24%)
Find more stocks in the Stock Screener


